Latest Headlines

Latest Headlines

Next up on Thermo Fisher's to-do list? Some serious M&A;: Analyst

Thermo Fisher Scientific is no stranger to M&A.; In the past few years, the company has struck a series of deals to beef up in diagnostics, including its $13.6 billion pact for DNA sequencing giant Life Technologies. Now Thermo Fisher could be revving up its dealmaking engine again, one analyst says.

VCA adds 56 veterinary clinics by snapping up $344M stake in Las Vegas chain

VCA said on February 29 that it would buy up an 80% stake in Companion Animal Practices North America, a Las Vegas-based chain of 56 veterinary hospitals.

Beleaguered Toshiba eyes Fujifilm for sale of medical device biz: WSJ

Battle-weary Toshiba is barreling toward the finish line in a sale of its medical device unit, and fellow Japanese devicemaker Fujifilm could emerge the winner in a potential $6 billion deal.

Synexus buys Research Across America, gaining first access to the U.S.

The site management organization Synexus has strengthened its global reach with the acquisition of Research Across America, marking its arrival into the lucrative U.S. market.

Voice box maker Atos Medical goes on the chopping block for €1B: WSJ

In the latest chapter of med tech M&A;, Swedish private equity firm EQT Holdings is putting local medical device company Atos Medical up for sale for about €1 billion ($1.1 billion).

Sanofi scouts for rare disease buyouts as Shire bears down on the field

Sanofi made a splash in rare disease R&D; when it traded $20 billion for Genzyme in 2011, and now the French drugmaker is on the hunt for deals "up to" that size as acquisitive rival Shire angles to dominate the space.

Battle-worn Toshiba mulls sale of medical business amid rising restructuring costs

Long-beleaguered Toshiba is planning on selling its entire medical equipment unit as it grapples with rising restructuring costs. The move comes as the Japanese company attempts to recover from an accounting scandal that has taken a hefty toll on business.

Indian pharma snaps up U.S. manufacturing with $1.5B worth of deals in 2015

Cipla closed a $550 million deal last week that got the Indian drugmaker its first U.S. manufacturing facility and a bunch of new products. Cipla's deal was just one of more than 30 that Indian drugmakers have made in the U.S. in the last the 5 years as they seek to get their hands on technology that would be hard to duplicate in India.

Recipharm buying Italian specialist

Recipharm has been continent-hopping to do a series of deals that expand both its geographic reach and its capabilities. Last fall, it struck a deal to buy an Indian company, and now the Sweden-based contract manufacturer says it is snapping up an antibiotics specialist in Italy.

Pfizer workers, retirees face big tax bills from $160B Allergan deal

Big-time Pfizer investors are no doubt prepared for the tax hit from its forthcoming merger with Allergan. But smaller shareholders, including current and retired employees, could face tax liabilities they're not ready for.